
The OTC Guide®, presented by Pharmacy Times®, is the premier resource for the top recommended OTC products designed to help consumers make informed decisions based on the expert opinions of our pharmacy readers. Featuring insights from thousands of pharmacists, the OTC Guide helps improve patient outcomes through timely and relevant information.

NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Frank Qian, MD, MPH, discusses the integration of omega-3 fatty acid therapy alongside statins and PCSK9 inhibitors in cardiovascular risk management, highlighting the distinct mechanisms of benefit and lack of significant drug interactions.

NLA 2025: Exploring the Evidence Behind Omega-3 Fatty Acids for Cardiovascular Risk
Frank Qian, MD, MPH, discusses the clinical indications, dosing strategies, and cardiovascular outcomes data for prescription omega-3 fatty acids, including the ongoing debate about EPA vs EPA-DHA formulations and the implications of recent trial findings.

Advertisement
Advertisement























.jpeg?fit=crop&auto=format)




